Cholesterol sequestrant glycosides that inhibit intestinal...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/715 (2006.01) A01N 31/00 (2006.01) A01N 43/04 (2006.01) A01N 45/00 (2006.01) A61K 31/56 (2006.01) A61K 31/58 (2006.01)

Patent

CA 2165782

Glycosides having neotigogenin aglycone moieties, administered orally to mammals, are shown to inhibit the absorption of cholesterol. These compounds are useful in the treatment of hypercholesterolemia. Particular compounds are derived from tomato seeds and include neotigogenin trisaccharide.

On a démontré que des glycosides comportant des fractions d'aglycone de néotigogénine inhibent l'absorption de cholestérol, lorsqu'ils sont administrés par voie orale à des mammifères. Ces composés sont utiles dans le traitement de l'hypercholestérolémie. Des composés particuliers sont obtenus à partir de graines de tomate et on trouve parmi ceux-ci le trisaccharide de néotigogénine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cholesterol sequestrant glycosides that inhibit intestinal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cholesterol sequestrant glycosides that inhibit intestinal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholesterol sequestrant glycosides that inhibit intestinal... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1977918

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.